Industry Perspective: Novartis

This program will use a case-based approach to review the clinical impact of recent developments in the treatment of chronic heart failure.

Speaker(s): Jane Wilcox, MD, MSc, Chicago, IL

Audience: Cardiologists and Hospitalists

Learning Objectives: 

• Provide education on an available treatment option for Heart Failure

Cost: Complimentary to all learners, HFSA members and non-members.*

*To download a webinar, users must create an account or have an existing account with the HFSA Learning Center to access the webinar. 

Disclaimer: The content in this webinar represents the beliefs of the speakers and do not necessarily represent the views of Novartis or HFSA. 

The activity “Evolving the Chronic Heart Failure Treatment Paradigm in Cardiology (2 of 2)” is not sponsored or endorsed by the HFSA. The webinar is not offered in the HFSA-accredited continuing education catalog; therefore, it is ineligible for continuing education units. No committee members or representatives of the HFSA have been involved in the planning of this activity.

This program provides an update on chronic heart failure (HF) for the nursing professional. Key discussion topics include an overview of HF, limitations of left ventricular ejection fraction in the classification of HF, and the importance and impact of nursing professionals in managing patients with HF during and after hospitalization.

Speaker(s): Lisa D. Rathman, CRNP, Lancaster, PA

Audience: Healthcare professionals who manage the care of heart failure patients.

Learning Objectives: 

• To provide an overview of the clinical definition, signs and symptoms, and features of chronic heart failure (HF)
• To discuss the assessment of HF, including clinical and technical limitations of left ventricular ejection fraction measurements
• To highlight the critical role of nursing professionals across the HF patient journey

Cost: Complimentary to all learners, HFSA members and non-members.*

*To download a webinar, users must create an account or have an existing account with the HFSA Learning Center to access the webinar. 

Disclaimer: The content in this webinar represents the beliefs of the speakers and do not necessarily represent the views of Novartis or HFSA. 

The activity “The Heart Failure Patient Journey: Impact of Nursing Professionals” is not sponsored or endorsed by the HFSA. The webinar is not offered in the HFSA-accredited continuing education catalog; therefore, it is ineligible for continuing education units. No committee members or representatives of the HFSA have been involved in the planning of this activity.

This program will use a case-based approach to review the clinical impact of recent developments in the treatment of chronic heart failure.

Speaker(s): J. Thomas Heywood, MD, FACC, Scripps Clinic, La Jolla, CA

Audience: Healthcare professionals who manage the care of heart failure patients.

Learning Objectives: 

• Provide education on a guideline recommended treatment for Heart Failure

Cost: Complimentary to all learners, HFSA members and non-members.*

*To download a webinar, users must create an account or have an existing account with the HFSA Learning Center to access the webinar. 

Disclaimer: The content in this webinar represents the beliefs of the speakers and do not necessarily represent the views of Novartis or HFSA. 

The activity “Evolving the Chronic Heart Failure Treatment Paradigm in Cardiology (1 of 2)” is not sponsored or endorsed by the HFSA. The webinar is not offered in the HFSA-accredited continuing education catalog; therefore, it is ineligible for continuing education units. No committee members or representatives of the HFSA have been involved in the planning of this activity.

This program provides a historical perspective and critical evaluation of left ventricular ejection fraction (LVEF) as a disease measure in heart failure (HF). The strengths and limitations of LVEF, as well as potential alternative imaging approaches and biomarkers for HF, are discussed. The trajectory of care for patients across the spectrum of LVEF is also highlighted.

Speaker(s): Michael H. Picard, MD., Boston, MA

Audience: Healthcare professionals who manage the care of heart failure patients.

Learning Objectives: 

• To provide a historical perspective and critical evaluation of LVEF as a disease measure in HF
• To describe potential future imaging approached and biomarkers in the management of HF
• To highlight the trajectory of care for patients across the spectrum of LVEF

Cost: Complimentary to all learners, HFSA members and non-members.*

*To download a webinar, users must create an account or have an existing account with the HFSA Learning Center to access the webinar. 

Disclaimer: The content in this webinar represents the beliefs of the speakers and do not necessarily represent the views of Novartis or HFSA. 

The activity “Left Ventricular Ejection Fraction: Past, Present, and Future Role in Heart Failure Care” is not sponsored or endorsed by the HFSA. The webinar is not offered in the HFSA-accredited continuing education catalog; therefore, it is ineligible for continuing education units. No committee members or representatives of the HFSA have been involved in the planning of this activity.